The main thrust of Prof. Rahimipour’s lab is the study of protein misfolding diseases, including Alzheimer’s and Parkinson’s, using self-assembling cyclic D,L-α-peptides that target toxic amyloid oligomers and cross the blood–brain barrier.
The main thrust of Prof. Rahimipour’s lab is the study of protein misfolding diseases, including Alzheimer’s and Parkinson’s, using self-assembling cyclic D,L-α-peptides that target toxic amyloid oligomers and cross the blood–brain barrier.